Drug intelligence / Profile preview

Benza

Development stage
Unknown
Lead developer
Alinamin Pharmaceutical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

**Benza** is a prominent brand of over-the-counter (OTC) cold, cough, and rhinitis remedies developed and marketed by **Alinamin Pharmaceutical** (formerly Takeda Consumer Healthcare) in Japan. The Benza product line includes various specialized formulations tailored to target specific cold symptoms, such as sore throat, fever, runny nose, nasal congestion, and cough. These products are typically multi-ingredient fixed-dose combinations containing active pharmaceutical ingredients such as ibuprofen or acetaminophen (for pain and fever relief), pseudoephedrine hydrochloride (a nasal decongestant), d-chlorpheniramine maleate (an antihistamine), tranexamic acid (to reduce mucosal inflammation), and dihydrocodeine phosphate (a cough suppressant). Benza products are widely marketed in Japan in various dosage forms, including tablets, caplets, liquids, troches, and sprays, and are approved for the symptomatic relief of the common cold, allergic rhinitis, and sinusitis.

Brand names
BenzaBenza Ace A JoBenza Bienyaku αBenza Block IPBenza Block IP PremiumBenza Block IP Premium JoBenza Block LBenza Block L PremiumBenza Block L Premium JoBenza Block Nodo SprayBenza Block SBenza Block S PremiumBenza Block S Premium JoBenza Block Sekidome EkiBenza Block Sekidome JoBenza Block TrocheBenza Block Yasumo
Other names
Benza AceBenza BienyakuBenza BlockBenza Nodo SprayBenza SekidomeBenza Troche
02

Targets

ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)MOR (Mu opioid receptor)PLG (Plasminogen)

Beyond the preview

Go deeper on Benza.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Benza.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call